Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
With a market cap of 143.68B, Pfizer(PFE) trades at $25.29. The stock has a price-to-earnings ratio of 14.74 and currently yields dividends of 6.8%.
On 2026-01-09, Pfizer(PFE) stock moved within a range of $25.13 to $25.56. With shares now at $25.29, the stock is trading +0.6% above its intraday low and -1.0% below the session's peak.
Trading volume for Pfizer(PFE) stock has reached 42.98M, versus its average volume of 36.62M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $27.69 and a low of $20.92.
PFE News
These high-yielding dividend stocks pay 5% or more, and make for safe income investments to hold on to. Dividend stocks can be the ultimate investments to buy...
If you are wondering whether Pfizer's current share price offers good value, this article will walk through what the latest data suggests and how to think about...
Pfizer Inc. ( ) will pay a dividend of $0.43 on the 6th of March. This makes the dividend yield 6.8%, which will augment investor returns quite nicely. Adverti...
Analyst ratings
56%
of 27 ratingsMore PFE News
Key Points Promising clinical results in 2026 could set the stage for Pfizer's stock to rebound. However, the company's COVID-19 product and patent cliff chal...
Pfizer's been focusing on a hot area of healthcare recently: GLP-1 drugs. Did you know that in just the past three years, healthcare giant Pfizer (PFE 0.83%) h...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful investing tools f...
Pfizer (PFE) has received a new Hold rating, initiated by UBS analyst, Michael Yee. Claim 70% Off TipRanks Premium Unlock hedge fund-level data and powerful inv...
UBS assumed coverage of Pfizer (PFE) with a Neutral rating and $25 price target The firm noted a backdrop of continued revenue uncertainty with $15B-$20B in rev...
Earlier this week, Pfizer confirmed broad list price increases for roughly 80 branded medicines for 2026, including a 15% hike for COVID vaccine Comirnaty, fram...
Investors seem to be underestimating this company's foreseeable future. The average blue chip dividend stock's current yield is somewhere in the ballpark of 3%...
